Securities Code: 002898
Securities Abbreviation: Sailong Delisting
Announcement Number: 2026-073
Sailong Pharmaceutical Group Co., Ltd.
Second Risk Warning Announcement on Company Stock Entering Delisting Stage Trading
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or significant omissions.
Special Risk Warning:
-
The shares of Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") will be delisted on the next trading day after the delisting stage ends, and the Company's shares will be terminated from listing.
-
The Company's shares resumed trading and entered the delisting stage on June 26, 2026. The delisting stage lasts for fifteen trading days, with the expected last trading day being July 16, 2026. Today is the fifth trading day, with ten remaining trading days. Upon expiration of the trading period, the shares will be terminated from listing. Investors are urged to invest prudently and be aware of the risks.
-
During the trading period of the Company's shares in the delisting stage, the Company will not plan or implement any major asset restructuring.
-
Investors, securities companies, and other market participants are requested to promptly settle stock pledge repurchase, agreed repurchase, margin financing, securities lending, and other businesses before the stock delisting.
-
For judicial freezing businesses that expire after the stock delisting and before the initial registration period of the two-network company and delisted company board (hereinafter referred to as the "delisting board") established and managed by Shenzhen Securities Transfer Exchange Co., Ltd. on behalf of the original securities company is completed, it is recommended that the competent authorities handle the renewal of freezing procedures through the original channels assisting in execution before the stock delisting.